Search

Your search keyword '"Apotheek Klinische Farmacie"' showing total 193 results

Search Constraints

Start Over You searched for: Author "Apotheek Klinische Farmacie" Remove constraint Author: "Apotheek Klinische Farmacie"
193 results on '"Apotheek Klinische Farmacie"'

Search Results

1. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

3. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

4. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

7. Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube

8. Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan (European Journal of Human Genetics, (2023), 31, 9, (982-987), 10.1038/s41431-022-01243-2)

9. Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan

10. Functional determination of emicizumab in presence of factor VIII activity

11. Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients

12. Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration

13. Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity

14. Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives

15. Limited excretion of dupilumab into breastmilk: A case report

16. Ion suppression, reduced long-term robustness and leakage current of the spray voltage during the ionization of trichloroacetic acid; a case study with a methylmalonic acid assay

17. Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

18. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease

19. Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy

20. Combining text mining with clinical decision support in clinical practice: a scoping review

21. Pharmacological protection of the thyroid gland against radiation damage from radioactive iodine labeled compounds in children: a systematic review

22. The association between patient satisfaction with information and adherence to oral anticancer agents

23. Candida keratitis and endopthalmitis after corneal transplantation; two case reports, a novel regimen and literature overview of therapeutic options

24. Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis

25. An easy, fast, and efficient assay for the quantification of peptide Hepcidin-25 in serum and plasma with LC-MS/MS

26. Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle

27. Clinical reasoning by pharmacists: A scoping review

29. Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia

30. CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)

32. Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension

33. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

34. Deprescriptie van psychofarmaca; praktijk en behoeften van patiënten en naasten

35. Medicamenteuze behandeling covid-19 in de tweede lijn

36. Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study

37. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients

38. Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward

39. Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting

41. Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

42. Erratum to: Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial

43. Unbound Plasma, Total Plasma and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation (vol 59, pg 771, 2020)

44. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

45. Identifying adverse drug reactions from free-text electronic hospital health record notes

46. Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

47. Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients

49. Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial

50. Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

Catalog

Books, media, physical & digital resources